Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H25NO4 |
| Molecular Weight | 355.4275 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
N[C@@H](C[C@H](CCCC(C1=CC=CC=C1)C2=CC=CC=C2)C(O)=O)C(O)=O
InChI
InChIKey=DWLOVDOPFJPWNE-HKUYNNGSSA-N
InChI=1S/C21H25NO4/c22-19(21(25)26)14-17(20(23)24)12-7-13-18(15-8-3-1-4-9-15)16-10-5-2-6-11-16/h1-6,8-11,17-19H,7,12-14,22H2,(H,23,24)(H,25,26)/t17-,19-/m0/s1
| Molecular Formula | C21H25NO4 |
| Molecular Weight | 355.4275 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:40:13 GMT 2025
by
admin
on
Wed Apr 02 08:40:13 GMT 2025
|
| Record UNII |
ZU8PFA9K8G
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
ZU8PFA9K8G
Created by
admin on Wed Apr 02 08:40:13 GMT 2025 , Edited by admin on Wed Apr 02 08:40:13 GMT 2025
|
PRIMARY | |||
|
6324634
Created by
admin on Wed Apr 02 08:40:13 GMT 2025 , Edited by admin on Wed Apr 02 08:40:13 GMT 2025
|
PRIMARY | |||
|
LY-307,452
Created by
admin on Wed Apr 02 08:40:13 GMT 2025 , Edited by admin on Wed Apr 02 08:40:13 GMT 2025
|
PRIMARY | |||
|
DTXSID401028586
Created by
admin on Wed Apr 02 08:40:13 GMT 2025 , Edited by admin on Wed Apr 02 08:40:13 GMT 2025
|
PRIMARY | |||
|
174393-13-6
Created by
admin on Wed Apr 02 08:40:13 GMT 2025 , Edited by admin on Wed Apr 02 08:40:13 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
ANTAGONIST
|
||
|
TARGET -> INHIBITOR |
ANTAGONIST
|